Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients

Recruiting

Trial ID: NCT05441696

Purpose

Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission

Official Title

Pilot Study for the Evaluation of ezCVP in Heart Failure Patients

Stanford Investigator(s)

Masataka Kawana

Assistant Professor of Medicine (Cardiovascular Medicine)

Eligibility


Inclusion Criteria:

   - Arm circumference of 23 cm to 55 cm

   - Subject admitted to the hospital with acute exacerbation of heart failure, with either
   reduced or preserved ejection fraction

   - Subject is at risk for readmission (NYHA Functional Classification 2-3)

   - Subject is able to understand the risks and potential benefits of participating in the
   study and is willing to provide written, informed consent

   - ezCVP indicator is high (CVPNI is over 9 mmHg) at admission

   - Subject is willing and able to comply with protocol procedures

   - Subject tested negative for COVID test after admission to the hospital

Exclusion Criteria:

   - Finger and upper arm anatomical anomaly or disease that may interfere with attaching a
   pulse oximeter sensor and/or blood pressure cuff

   - Pregnant (self-reported)

   - Upper extremity DVT (currently being treated)

   - Severe skin disease involving the upper arm(s)

   - Study investigator may exclude patients based on clinical judgement

Intervention(s):

device: ezCVP measurement

Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305